Abstract e aim of this study was to analyze the importance of the peritoneal equilibration test (PET) in evaluation of the peritoneal membrane tranport status in patients treated with continuous ambulatory peritoneal dialysis (CAPD). e study included  adult continuous ambulatory peritoneal dialysis (CAPD) patients,  male and  female, mean age  ± , years with a prescription of four exchanges of  litres (L) per day, who underwent peritoneal equilibration test (PET). Eleven of patients were diabetics. A modifi ed PET was performed during a  hours dwell using , glucose dialysis solution. e dialysate/ plasma ratio of creatinine (D/P) at the end of the procedure, and the dialysate  min/ initial dialysate ratio of glucose (D/D) were calculated and used as parametar of solute transport. With the test, chategorisation of patients was possible into high (H), high-average (HA), low average (LA), and low (L) transporters. In multivariate analysis age, gender, time on dialysis, comorbid diseases, diabetes mellitus (DM), serum albumin, were concidered as independent factors infl uencing the PET. Among  patients  (,) were classifi ed as H transpoters,  () as HA, and  (,) as LA. ere were no patients in low category. Creatinine D/P at  hours was not diff erent DM and non-DM patients.
Introduction
Peritoneal membrane function in patients on peritoneal dialysis influenced dialysis prescription, clinical outcome and may be changed with time on treatment. For the adequate prescription of peritoneal dialysis, peritoneal transport characteristics should be known. e most widely used test for classifying a patient's peritoneal type has been the peritoneal equilibration test (PET). e originally test, developed and described by Twardovski, was performed using a , glucose solution and focused on transport of small solutes () . Most nephrologists use the PET which is performed during a  h dwell with a , glucose dialysis solution instead of the , glucose solution because it was more sensitive to detect clinically signifi cant ultrafi ltration failure () . It allowed assessment a number of aspects of membrane function including solute transport rates, ultrafi ltration capacity, eff ective reabsorbtion, transcellular water transport, and permeability to macromolecules. Intra-individual changes can than be detected and adjustments can be made. Also, the results of interventions can be examined and complications can be detected at an early stage. e aim of this study was to analyze the importance of the PET in evaluation of the peritoneal membrane tranport status in patients treated with continuous ambulatory peritoneal dialysis (CAPD) and factors influencing the peritoneal transport rate.
Materials and Methods
A prospective single centar study was used with longterm follow up. e study included  adult continuous ambulatory peritoneal dialysis (CAPD) patients,  male and  female, mean ages  ± , years with a prescription of four exchanges of  L per day, who underwent peritoneal equilibration test (PET). Eleven of patients were diabetics included both type I and type II. Other causes of their chronic uremia included chronic glomerulonephritis ( cases), chronic pyelonephritis ( cases), hypertensive nephropathy ( cases), endemic nephropathy ( case) and refl ux nephropathy ( case) . Cardiovascular disease (CVD; defi ned as previous history of congestive heart failure, myocardial infarction, angina, peripheral vascular disease, or cerebrovascular disease) was presented in  patients. Of  diabetics patients  had CVD. Respiratory disease (chronic lung disease) had one patient. No restriction criteria were applied for age, gender, comorbid diseases, serum albumin. Patients on immunosuppressive therapy and those with hepatitis, and those having a peritonitis episode within the previous  days, or three or more episodes during the previous  months, were excluded. Each patient underwent the PET . e PET was done in the standard way, using  L of , glucose concentration dialysate. Samples were drawn at ,  and  hours, and the blood sample was drawn at hour . e dialysate/plasma ratio of creatinine (D/P Cr) at the end of the procedure, and the dialysate  min/initial dialysate ratio of glucose (Dt/D) are calculated and are used as parameter of solute transport. With the test, categorization of patients was possible into high (H), high-average (HA), low-average (LA) and low (L) transporters. e mean D/P creatinine ratio at  hours was ,. Patients with D/P creatinine values lower than , showed low transport characteristics and high -hour dyalisate glucose level, which was greater than , mmol/L. In patients with high solute transport D/P creatinine ratio has been ,-, and the -hour dyalisate glucose level was less than , mmol/L. e ultrafi ltration capacity can be defi ned as the net fl uid removed during a standardized exchange, after  hours using , glucose solution. e diagnosis membrane failure can be made when the net ultrafi ltered volume is < ml after a standardized h dwell using a , glucose solution (ISPD Guidelines) () . Glucose, urea, and creatinine were measured in each sample, using conventional techniques in a centralized reference laboratory.
Statistics
Results are expressed as mean ± standard deviation (SD). The ANOVA test was used to compare the difference in clinical characteristics between different transporter groups. Comparison of the differences in the subgroups was made using the t test and Kruskal Wallis test. A difference was considered significant when the p value was less than ..
Results
Of  patients,  (,) were classifi ed as H transporters,  () as HA, and  (,) as LA transporters. There were no patients in low category. The distribution of creatinine D/P ratio from the PET is shown in Table  . In the study group, the mean D/P creatinine ratio at  hours in patients with high solute transport was , ±, and the dialysate  min/ initial dialysate ratio of glucose (Dt/D) was ,±,; in patients with low-average solute transport D/P creatinine ratio was , ±, and the glucose ratio (Dt/D) level was greater ,±,. The ultrafiltration capacity results on the PET has been linked with the results
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of glucose absorbtion and D/P creatinine ratios were as follows : , ± , L (H), , ± , L (HA) and , ± , L (LA). We also examined a drop in dialysate sodium during the fi rst hour of a , exchange. It was greater than  mmol/L in all transport groups and ultrafi ltration failure via water channels were ruled out.
The clinical characteristics of four transport groups of CAPD patients are shown in Table  .
There were significant differences in gender, comorbid diseases, initial serum albumin, D/D glucose, and the volume drained in  hours. The H transporters had high proportion of man, more comorbide diseases, lower initial serum albumin, lower D/D glucose and lower drained volume. The H transporters had a signifi cantly higher proportion of CVD, but not diabetes or respiratory disease. e distribution of comorbid disease according to gender is shown Table   . Male patients had signifi cantly more comorbid disease, overall and more diabetes compared to female.
Values are expressed as mean as percentages and absolute frequencies.
Discussion
The present study shows that CAPD patients, who were high transporters at the start of CAPD, had more comorbid diseases, a higher proportion of males, lower serum albumin and lower drained volumes. We found that high peritoneal transport rate was related to comorbid diseases. It is generally accepted that peritoneal transport rate depends on both eff ective peritoneal surface area and permeability and that peritoneal permeability is aff ected by peritoneal blood circulation (,) . Many of the mediators produced in the infl ammatory process can aff ect microvascular permeability and vascular tone () . us, our fi nding of a signifi cant relation between peritoneal transport rate and comorbid diseases suggests that comorbid diseases may affect microcirculation, and may also aff ect peritoneal transport characteristics at the start of CAPD () . e CANUSA study showed that a grater proportion of patients had diabetes mellitus with higher peritoneal membrane transport rate, according to PET at  month after initiation of dialysis (). Reyes et al. reported that initial D/P Cr was significantly higher in patients with CVD () .
In the present study, high transporters had more CVD compared to the other groups. e signifi cantly higher proportion of men in the high transporter group is also consistent with previous studies (,) . In a study of  CAPD patients, Devuyst et Legend: H = high transporter; HA = high-average transporter ; LA = low -average transporter; L = low transporter; CVD = cardiovascular disease; D2/P2 Cr = dialysate-to-plasma creatinine concentration ratio at 2 hours of dwell; D4/P4 Cr = dialysate-to-plasma creatinine concentration ratio at 4 hours of dwell; D4/D0 glucose = concentration ratio of dialysate glucose at 4 hours and at 0 dwell time; D/P Na = dialysate-to-plasma; Values are express as mean as ± standard deviation Legend: H = high transporter; HA = high-average transporter ; LA = low -average transporter ; L = low transporter; CVD = cardiovascular disease;D4/P4 Cr = dialysate-to-plasma creatinine concentration ratio at 4 hours of dwell; D4/D0 glucose = concentration ratio of dialysate glucose at 4 hours and at 0 dwell time; Values are express as mean as ± standard deviation except for gander, diabetes mellitus, CVD and respiratory wich are absolute frequencies and percentages () . e CANUSA study showed a signifi cantly increased proportion of man with increased transport rate () . e cause of this eff ect is not clear. However, our fi nding of signifi cantly more comorbid diseases in male patients leads us to speculate that the eff ect of comorbid diseases on the peritoneal transport rate may explain the relation between men and high transport rate. The CANUSA study showed that increased transport rate was associated with low serum albumin but not with other initial nutritional parameters such as subjective global assessment, percent lean body mass, or normalized protein catabolic rate () . In addition to comorbid diseases, our study reveals that initial serum albumin concentration is significantly lower in initial H peritoneal transport rate, a finding consistent with previous reports. Coester et al. found that initial D/P Cr was negatively correlated with initial serum albumin and positively correlated with low hyaluronan () . Acute and chronic infections and inflammation are present in a large proportion of predialysis patients, and serum albumin is generally accepted as an indicator of inflammation (). Cueto-Manzano and Correa-Rotter showed that diabetes mellitus was signifi cantly more frequent in high transporters, and was the most important risk factor for mortality while on CAPD () . In the present study, however, we found no signifi cant diff erence in the proportion of diabetics among diff erent transport groups. Of our  diabetic's patients,  had CVD. Some diabetic patients had more than one comorbid disease. e high rate of comorbid disease in diabetes explains why diabetes is not an independent risk factor for mortality, while CVD and respiratory disease are.
Conclusion
e proper classifi cation of patient peritoneal transport type is an important issue in the practice of peritoneal dialysis. e patients classifi ed as high transporters have more comorbide diseases, lower initial serum albumin, lower D/D glucose, lower drained volume and a higher mortality risk than patients classifi ed in other transport categories. 
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